Advanced in Otitis Media with Effusion

Takao Fujisawa

Kashiwa, JP 
Advanced in Otitis Media with Effusion
Kashiwa, JP 
OverviewLocationsClinical Research

Overview

Takao Fujisawa practices in Kashiwa, Japan. Mr. Fujisawa is rated as an Advanced expert by MediFind in the treatment of Otitis Media with Effusion. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Asthma, Anaphylaxis, and Otitis Media with Effusion.

His clinical research consists of co-authoring 226 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Otitis Media with Effusion.

Gender
Male

Locations

Kashiwa, Japan
Other Locations
Tsu, 5140125, Japan
Course Of Advanced Clinical Research Of Cancer, Tokyo, Japan
Department Of Head And Neck Medical Oncology/Translational Research Support Office, Chiba, Japan
Chiyoda, 1010062, Japan
Japan
Miemachi, Japan
Hongo, 1130033, Japan
Kanazawa, 9201192, Japan
Sapporo, Japan
Kobe, Japan
Toyama, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, Topical Corticosteroid
Study Phase: Phase 3

226 Total Publications

Clinical Significance of Extrachromosomal DNA in FGFR2-Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience.
Clinical Significance of Extrachromosomal DNA in FGFR2-Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience.
Journal: JCO precision oncology
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fujisawa's expertise for a condition
ConditionClose
      View All 18 Advanced Conditions
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile